Screener
Bruker BRKR Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bsi Biospin | $195.7M+0.2% | $197.5M-5.0% | $267M-2.0% | $208.7M-10.4% | $195.3M-10.2% | |
| Bsi Calid | $310.3M+8.6% | $316.3M+12.9% | $331.6M+3.4% | $312.7M+11.9% | $285.8M+7.6% | |
| Bsi Nano | $261.3M+3.6% | $246M-4.1% | $309.1M-2.9% | $266.5M-7.2% | $252.1M-0.2% | |
| Energy And Supercon Technologies | $74.2M+11.9% | $66.8M+12.6% | $71.5M-0.8% | $73.8M+7.4% | $66.3M-4.1% | |
| Revenue by Product | ||||||
| Product And Service Other | $174.8M+7.4% | $177M+12.0% | $179.9M+5.2% | $169.4M+9.2% | $162.7M+11.2% | |
| Product | $663.7M+4.6% | $646.4M+0.5% | $797.3M-1.4% | $691.1M-2.6% | $634.7M-3.0% | |
| Revenue by Geography | ||||||
| Asia Pacific Excluding China | $112.4M-11.8% | $134.7M+2.5% | $163.1M-0.7% | $130.7M-7.4% | $127.4M+20.0% | |
| CN | $104.9M-8.5% | $74M-26.9% | $138.1M+21.4% | $121.8M+0.4% | $114.7M-4.7% | |
| DE | $64.4M+9.0% | $62.7M+2.6% | $105.5M+22.5% | $71.3M-4.0% | $59.1M-29.2% | |
| Europe Excluding Germany | $244.3M+14.5% | $258.9M+15.5% | $271.5M-5.4% | $241.2M+11.9% | $213.4M+11.0% | |
| Other Country | $64.3M+7.3% | $71.2M+7.6% | $74M+9.6% | $69.5M-4.9% | $59.9M+9.7% | |
| US | $248.2M+11.4% | $221.9M+2.1% | $225M-13.8% | $226M-5.4% | $222.9M-8.5% |
FAQ
- How does Bruker break its business down?
- Bruker (BRKR) reports revenue by business across 4 parts — Bsi Biospin, Bsi Calid, Bsi Nano and Energy And Supercon Technologies. Each is extracted from the segment footnotes and tracked over time.
- Where does Bruker's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bruker's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
